Harnessing microRNA biology to treat
    cardiovascular and muscle disease
Sunday February 05, 2012
 
Job Postings

MiRagen Therapeutics, Inc., a pre-clinical stage biopharmaceutical company, was founded in 2007 to develop innovative microRNA-based therapeutics for cardiovascular and muscle disease.  MicroRNAs are short, single-stranded RNA molecules encoded in the genome that regulate gene expression and play a vital role in influencing cardiovascular and muscle disease.

Cardiovascular disease is the leading cause of death globally and represents an enormous burden on global healthcare systems.  MiRagen combines world recognized leadership in cardiovascular medicine with unprecedented in-house expertise in microRNA biology and chemistry.  In October 2011, miRagen and Les Laboratoires Servier, a leading European pharmaceutical company, entered into a strategic alliance for the research and development of microRNA-based therapeutics in cardiovascular disease.  The alliance further validates our innovative technology platforms and provides future opportunities for growth.

We continually seek highly committed individuals who have a true passion for revolutionary science and a desire to be part of a dynamic, cross-functional team.  Interested individuals can apply for a specific position below or submit a cover letter and resume to hr@miragenrx.com

 

 

 

 

 

 

 

 

 


Search Firms
miRagen does not accept unsolicited resumes from staffing vendors, including recruitment agencies and/or search firms, nor does miRagen pay fees to any such vendors without a current agreement on file. Please do not contact or solicit miRagen hiring managers regarding these matters.